Effects of chronic sodium alendronate on depression and anxiety in a menopausal experimental model.

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Pharmacology, Biochemistry and Behavior

• Publication date

  2015-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.pbb.2014.12.006PMID 25542587
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Association of physical activity with future mental health in older, mid-life and younger women

  2014cited by this paper
• Established and forthcoming drugs for the treatment of osteoporosis

  2014cited by this paper
• Prevention and treatment of postmenopausal osteoporosis.

  2014cited by this paper
• Differential impact of the Bisphosphonate Alendronate on undifferentiated and terminally differentiated human myogenic cells

  2014cited by this paper
• Estradiol decreases rat depressive behavior by estrogen receptor beta but not alpha: no correlation with plasma corticosterone

  2014cited by this paper
• Osteoporosis in menopause.

  2014cited by this paper
• An overview on the treatment of postmenopausal osteoporosis.

  2014cited by this paper
• Effects of estrogen, estrogen/progesteron combination and genistein treatments on oxidant/antioxidant status in the brain of ovariectomized rats.

  2013cited by this paper
• Established and forthcoming drugs for the treatment of osteoporosis.

  2013cited by this paper
• Compositional and material properties of rat bone after bisphosphonate and/or Strontium ranelate drug treatment.

  2013cited by this paper
• Vaginal effects of ospemifene in the ovariectomized rat preclinical model of menopause.

  2013cited by this paper
• Emerging therapies for the treatment of osteoporosis

  2013cited by this paper
• Comparison of orally administered bisphosphonate drugs in reducing the risk of hip fracture in older adults: a population-based cohort study.

  2013cited by this paper
• Ameliorating effects of aripiprazole on cognitive functions and depressive-like behavior in a genetic rat model of absence epilepsy and mild-depression comorbidity.

  2013cited by this paper
• Association of hormonal contraceptive use with reduced levels of depressive symptoms: a national study of sexually active women in the United States.

  2013cited by this paper
• Alendronate sodium hydrate (oral jelly) for the treatment of osteoporosis: review of a novel, easy to swallow formulation

  2013cited by this paper
• Neurosteroids, stress and depression: potential therapeutic opportunities.

  2013cited by this paper
• mTOR inhibition modulates epileptogenesis, seizures and depressive behavior in a genetic rat model of absence epilepsy.

  2013influential reference
• Increased blood oxidative stress in experimental menopause rat model: the effects of vitamin A low‐dose supplementation upon antioxidant status in bilateral ovariectomized rats

  2012cited by this paper
• Comparative uterine effects on ovariectomized rats after repeated treatment with different vaginal estrogen formulations.

  2012cited by this paper
• Synergistic effect of estradiol and fluoxetine in young adult and middle-aged female rats in two models of experimental depression.

  2012influential reference
• 17β-estradiol replacement in young, adult and middle-aged female ovariectomized rats promotes improvement of spatial reference memory and an antidepressant effect and alters monoamines and BDNF levels in memory- and depression-related brain areas.

  2012cited by this paper
• Long-term ovariectomy modulates the antidepressant-like action of estrogens, but not of antidepressants

  2011cited by this paper
• Reversible modulations of neuronal plasticity by VEGF

  2011cited by this paper
• 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary

  2010cited by this paper
• Chronic estradiol replacement to aged female rats reduces anxiety-like and depression-like behavior and enhances cognitive performance.

  2009influential reference
• Alendronate lowers cholesterol synthesis in the central nervous system of rats - a preliminary study.

  2009cited by this paper
• 5-HT(1A) receptor function in major depressive disorder.

  2009cited by this paper
• Mechanisms of Action of Estrogen in the Brain: Insights from Human Neuroimaging and Psychopharmacologic Studies

  2009influential reference
• Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy

  2008cited by this paper
• 5-HT1A receptors in the dorsal hippocampus mediate the anxiogenic effect induced by the stimulation of 5-HT neurons in the median raphe nucleus.

  2008cited by this paper
• Differential effects of ovarian steroids and raloxifene on serotonin 1A and 2C receptor protein expression in macaques

  2008cited by this paper
• The laboratory rat as an animal model for osteoporosis research.

  2008cited by this paper
• Relative effects of exercise training and alendronate treatment on skeletal muscle function of ovariectomized rats

  2007cited by this paper
• Estrogens, progestins, and risk of breast cancer.

  2007cited by this paper
• VEGF is an essential mediator of the neurogenic and behavioral actions of antidepressants

  2007cited by this paper
• Administration of estrogen receptor beta-specific selective estrogen receptor modulators to the hippocampus decrease anxiety and depressive behavior of ovariectomized rats.

  2007cited by this paper
• Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats.

  2006cited by this paper
• Alendronate Sodium in the Management of Osteoporosis

  2006cited by this paper
• Estrogen and brain-derived neurotrophic factor (BDNF) in hippocampus: complexity of steroid hormone-growth factor interactions in the adult CNS.

  2006cited by this paper
• Anxiolytic property of estrogen related to the changes of the monoamine levels in various brain regions of ovariectomized rats

  2006cited by this paper
• A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis.

  2005cited by this paper
• Changes in 5-HT1A receptor binding and G-protein activation in the rat brain after estrogen treatment: comparison with tamoxifen and raloxifene.

  2005cited by this paper
• Effect of acute and chronic 17β-estradiol treatment on serotonin and 5-hydroxyindole acetic acid content of discrete brain nuclei of ovariectomized rat

  2004cited by this paper
• Distribution of estrogen receptor α and β in the mouse central nervous system: In vivo autoradiographic and immunocytochemical analyses

  2004cited by this paper
• Expression of estrogen receptors (alpha, beta) and androgen receptor in serotonin neurons of the rat and mouse dorsal raphe nuclei; sex and species differences.

  2004cited by this paper
• Distribution of estrogen receptor alpha and beta in the mouse central nervous system: in vivo autoradiographic and immunocytochemical analyses.

  2004cited by this paper
• Expression of estrogen receptors (α, β) and androgen receptor in serotonin neurons of the rat and mouse dorsal raphe nuclei; sex and species differences

  2004cited by this paper
• Chronic fluoxetine induces opposite changes in G protein coupling at pre and postsynaptic 5-HT1A receptors in rat brain.

  2003cited by this paper
• Does estrogen enhance the antidepressant effects of fluoxetine?

  2003cited by this paper
• The human raphe nuclei and the serotonergic system.

  2003cited by this paper
• Estrogen Receptor Gene Expression in Relation to Neuropsychiatric Disorders

  2003cited by this paper
• Patterns of depressed mood across the menopausal transition: approaches to studying patterns in longitudinal data

  2002cited by this paper
• Epidemiology and outcomes of osteoporotic fractures.

  2002cited by this paper
• Determination of the estrous cycle phases of rats: some helpful considerations.

  2002cited by this paper
• Estrogen receptor beta (ERbeta) mRNA and protein in serotonin neurons of macaques.

  2001influential reference
• Efficacy of estradiol for the treatment of depressive disorders in perimenopausal women: a double-blind, randomized, placebo-controlled trial.

  2001cited by this paper
• Role of Estrogen in the Aetiology and Treatment of Mood Disorders

  2001cited by this paper
• Prevention and Treatment of Postmenopausal Osteoporosis

  1998cited by this paper
• Ovarian steroids and the brain

  1997cited by this paper
• The distribution of 5-HT1A and 5-HT2A receptor mRNA in human brain.

  1995cited by this paper
• Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group.

  1995cited by this paper
• The ovariectomized rat model of postmenopausal bone loss.

  1991cited by this paper

• Bone-Derived Factors: Regulating Brain and Treating Alzheimer’s Disease

  2025cites this paper
• Sex-specific bi‑directional association between osteoporosis and depression from the national representative data of South Korea

  2022cites this paper
• N-acetylcysteine aggravates seizures while improving depressive-like and cognitive impairment comorbidities in the WAG/Rij rat model of absence epilepsy

  2022cites this paper
• Evaluation of antidepressant effects of zoledronate in rats

  2021cites this paper
• Systemic effects of abnormal bone resorption on muscle, metabolism, and cognition.

  2021cites this paper
• Protective effect of metformin against ovariectomy induced depressive- and anxiety-like behaviours in rats: role of oxidative stress

  2021cites this paper
• Metabolic and Cognitive Effects of Ranolazine in Type 2 Diabetes Mellitus: Data from an in vivo Model

  2020cites this paper
• Are Bisphosphonates Associated with Adverse Metabolic and Cognitive Effects? A Study in Intact Rats and Rats Fed High-Fat High-Fructose Diet

  2020cites this paper
• Anxiolytic, antioxidant, and neuroprotective effects of goji berry polysaccharides in ovariectomized rats: experimental evidence from behavioral, biochemical, and immunohistochemical analyses

  2020cites this paper
• Impacts of Psychological Stress on Osteoporosis: Clinical Implications and Treatment Interactions

  2019cites this paper
• The Angiotensin Type 1 Receptor Antagonist Losartan Prevents Ovariectomy-Induced Cognitive Dysfunction and Anxiety-Like Behavior in Long Evans Rats

  2019cites this paper
• Perampanel chronic treatment does not induce tolerance and decreases tolerance to clobazam in genetically epilepsy prone rats.

  2018cites this paper
• Identification of Steroidogenic Components Derived From Gardenia jasminoides Ellis Potentially Useful for Treating Postmenopausal Syndrome

  2018cites this paper
• Genistein attenuates seizure-induced hippocampal brain-derived neurotrophic factor overexpression in ovariectomized rats.

  2018cites this paper
• Alendronate treatment induces IL-1B expression and apoptosis in glioblastoma cell line

  2018cites this paper
• Fingolimod Exerts only Temporary Antiepileptogenic Effects but Longer-Lasting Positive Effects on Behavior in the WAG/Rij Rat Absence Epilepsy Model

  2017cites this paper
• Zoledronic Acid Use and Risk of Cognitive Decline among Elderly Women and Men with Osteoporosis.

  2015cites this paper